Mozobil

Product manufactured by Sanofi-Aventis U.s. Llc

Application Nr Approved Date Route Status External Links
NDA022311 None Subcutaneous None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Mozobil Is Indicated In Combination With Granulocyte-Colony Stimulating Factor (G-Csf) To Mobilize Hematopoietic Stem Cells (Hscs) To The Peripheral Blood For Collection And Subsequent Autologous Transplantation In Patients With Non-Hodgkin's Lymphoma (Nhl) And Multiple Myeloma (Mm). Mozobil, A Hematopoietic Stem Cell Mobilizer, Is Indicated In Combination With Granulocyte-Colony Stimulating Factor (G-Csf) To Mobilize Hematopoietic Stem Cells (Hscs) To The Peripheral Blood For Collection And Subsequent Autologous Transplantation In Patients With Non-Hodgkin's Lymphoma And Multiple Myeloma. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Plerixafor PLERIXAFOR ZINC22443609

Comments